Literature DB >> 24060963

C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.

Daniel E Croker1, Reena Halai, David P Fairlie, Matthew A Cooper.   

Abstract

Receptors for C5a have an important role in innate immunity and inflammation where their expression and activation is tightly regulated. There are two known receptors for C5a: the C5a receptor (C5aR) and the C5a receptor like-2 (C5L2) receptor. Here we hypothesized that activation of C5aR might lead to heteromer formation with C5L2, as a downregulatory mechanism for C5aR signaling. To investigate this experimentally, bioluminescent resonance energy transfer (BRET) was implemented and supported by wide-field microscopy to analyze receptor localization in transfected HEK293 cells and human monocyte-derived macrophages (HMDM). BRET experiments indicated the presence of constitutive C5aR-C5L2 heteromers, where C5a, but not C5a-des Arg, was able to induce further heteromer formation, which was inhibited by a C5aR-specific antagonist. The data obtained suggest that C5aR-C5L2 can form heteromers in a process enhanced by C5a, but not by C5a-des Arg. There was also a significant difference in the levels of the anti-inflammatory cytokine IL-10 detected in HMDM following exposure to C5a compared with that seen for C5a-des Arg but no differences in the pro-inflammatory cytokines TNFα and IL-6. These subtle differences in C5a and C5a-des Arg induced receptor function may be of benefit in understanding the regulation of C5a in acute inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24060963     DOI: 10.1038/icb.2013.48

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  16 in total

1.  Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.

Authors:  Kathryn E Lillegard; Alex C Loeks-Johnson; Jonathan W Opacich; Jenna M Peterson; Ashley J Bauer; Barbara J Elmquist; Ronald R Regal; Jeffrey S Gilbert; Jean F Regal
Journal:  J Pharmacol Exp Ther       Date:  2014-08-22       Impact factor: 4.030

2.  Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.

Authors:  Daniel E Croker; Peter N Monk; Reena Halai; Geraldine Kaeslin; Zoe Schofield; Mike Cl Wu; Richard J Clark; Mark At Blaskovich; Dimitrios Morikis; Christodoulos A Floudas; Matthew A Cooper; Trent M Woodruff
Journal:  Immunol Cell Biol       Date:  2016-04-25       Impact factor: 5.126

3.  Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo.

Authors:  Declan M Gorman; Xaria X Li; Colton D Payne; Cedric S Cui; John D Lee; K Johan Rosengren; Trent M Woodruff; Richard J Clark
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-17

4.  Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.

Authors:  Shubhi Pandey; Xaria X Li; Ashish Srivastava; Mithu Baidya; Punita Kumari; Hemlata Dwivedi; Madhu Chaturvedi; Eshan Ghosh; Trent M Woodruff; Arun K Shukla
Journal:  J Biol Chem       Date:  2019-04-29       Impact factor: 5.157

5.  In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy.

Authors:  Cedric S Cui; Vinod Kumar; Declan M Gorman; Richard J Clark; John D Lee; Trent M Woodruff
Journal:  ACS Pharmacol Transl Sci       Date:  2021-12-21

6.  Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery.

Authors:  Reza Rezvani; Jessica Smith; Marc Lapointe; Picard Marceau; Andre Tchernof; Katherine Cianflone
Journal:  J Obes       Date:  2014

7.  Derivation of ligands for the complement C3a receptor from the C-terminus of C5a.

Authors:  Reena Halai; Meghan L Bellows-Peterson; Will Branchett; James Smadbeck; Chris A Kieslich; Daniel E Croker; Matthew A Cooper; Dimitrios Morikis; Trent M Woodruff; Christodoulos A Floudas; Peter N Monk
Journal:  Eur J Pharmacol       Date:  2014-10-30       Impact factor: 4.432

8.  T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.

Authors:  Giuseppina Arbore; Erin E West; Rosanne Spolski; Avril A B Robertson; Andreas Klos; Claudia Rheinheimer; Pavel Dutow; Trent M Woodruff; Zu Xi Yu; Luke A O'Neill; Rebecca C Coll; Alan Sher; Warren J Leonard; Jörg Köhl; Pete Monk; Matthew A Cooper; Matthew Arno; Behdad Afzali; Helen J Lachmann; Andrew P Cope; Katrin D Mayer-Barber; Claudia Kemper
Journal:  Science       Date:  2016-06-17       Impact factor: 47.728

9.  Association of immune and metabolic receptors C5aR and C5L2 with adiposity in women.

Authors:  Pegah Poursharifi; Reza Rezvani; Abhishek Gupta; Marc Lapointe; Picard Marceau; André Tchernof; Katherine Cianflone
Journal:  Mediators Inflamm       Date:  2014-01-12       Impact factor: 4.711

10.  Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways.

Authors:  Ling-Ling An; Jacob V Gorman; Geoffrey Stephens; Bonnie Swerdlow; Paul Warrener; Jessica Bonnell; Tomas Mustelin; Michael Fung; Roland Kolbeck
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.